Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > Abbott Antigen Test

<< Previous

Bullboard Posts

Next >>

Post by letsdoiton Jan 20, 2021 9:03pm

112 Views

Post# 32341480

RE: Abbott Antigen Test

CDC Study Finds Abbott BinaxNow SARS-CoV-2 Antigen Test Less Sensitive Than PCR, But Still Useful......... https://www.360dx.com/covid-19/cdc-study-finds-abbott-binaxnow-sars-cov-2-antigen-test-less-sensitive-pcr-still-useful?utm_source=Sailthru&utm_medium=email&utm_campaign=360DN Wed 2021-01-20&utm_term=360Dx Daily News#.YAjfsx7TU0M

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China